期刊
NUCLEAR MEDICINE AND BIOLOGY
卷 30, 期 4, 页码 417-427出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/S0969-8051(03)00019-2
关键词
radioimmunotherapy; (CU)-C-67; anti-L1-CAM antibody chCE7; renal carcinoma; PET imaging
In order to optimize radiocopper labeling of anti-L1-CAM antibody chCE7, five bifunctional copper chelators were synthesized and characterized (CPTA-N-hydoxysuccinimide, DO3A-L-p-isothiocyanato-phenylalanine, DOTA-PA-L-p-isocyanato-phenylalanine, DOTA-glycyl-L-p-isocyanato-phenylalanine and DOTA-triglycyl-L-p-isocyanato-phenylalanine). Substitution with more than 11 chelators per antibody molecule was found to influence immunoreactivity and biodistributions of Cu-67-MAb chCE7 significantly. CPTA-labeled antibody achieved the best tumor to normal tissue ratios when biodistributions of the different Cu-67-chCE7 conjugates were assessed in tumor-bearing mice. High resolution PET imaging with Cu-64-CPTA-labeled MAb chCE7 showed uptake in lymph nodes and heterogeneous distribution in tumor xenografts. (C) 2003 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据